Tyzine Pediatric

Tyzine Pediatric

Tyzine Pediatric Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Overdose in children may produce profound sedation. This may be accompanied by profuse sweating, hypotension or even shock (See "Overdosage").

General

Avoid doses greater or more frequent than those recommended below. Excessive dosage in children may, on rare occasions, cause severe drowsiness. Profuse sweating may accompany this effect. Overdosage may also cause marked hypotension or even shock. Use cautiously in patients with cardiovascular disease (e.g., coronary artery disease, hypertension), and metabolic-endocrine diseases (e.g., hyperthyroidism, diabetes).

Information for Patients

Patients should be advised to follow the prescribed dosage regimen. The spray should be administered with the head held upright. To spray, squeeze bottle quickly and firmly and sniff briskly. Instillation of the nose drops can be most conveniently accomplished with the patient in the lateral head-low position.

Drug Interactions
DRUG EFFECT
Monoamine Oxidase
(MAO) Inhibitors
Hypertension
Pregnancy
Pregnancy Category C

Animal reproduction studies have not been conducted with Tyzine®. It is also not known whether Tyzine® Nasal Solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tyzine® Nasal Solution should be given to a pregnant woman only if clearly needed.

Nursing Mothers

It is not known whether this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when Tyzine® Nasal Solution is administered to a nursing woman.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Tyzine® Nasal Solution is indicated for decongestion of nasal and nasopharyngeal mucosa.

History

There is currently no drug history available for this drug.

Other Information

Tyzine® Nasal Solution contains tetrahydrozoline hydrochloride, 2-(1,2,3,4-Tetrahydro-1, naphthyl)-2-imidazoline monohydrochloride, as a nasal decongestant. The chemical structure is:

tyzine-image01.jpg

Nasal Solution is available for topical nasal application as 0.1% nasal solution and as 0.05% pediatric nasal drops. The nasal solution is a solution of tetrahydrozoline hydrochloride in water, with sodium chloride, sodium citrate, edetate disodium, and benzalkonium chloride, with hydrochloric acid to adjust to the pH.

Tyzine Pediatric Manufacturers


  • Fougera Pharmaceuticals Inc.
    Tyzine Pediatric (Tetrahydrozoline Hydrochloride) Solution Tyzine (Tetrahydrozoline Hydrochloride) Solution [Fougera Pharmaceuticals Inc.]
  • Pharmaderm A Division Of Fougera Pharmaceuticals Inc.
    Tyzine Pediatric (Tetrahydrozoline Hydrochloride) Solution Tyzine (Tetrahydrozoline Hydrochloride) Solution [Pharmaderm A Division Of Fougera Pharmaceuticals Inc.]

Login To Your Free Account